TAM
LGND icon

Tocqueville Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Tocqueville Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-7,327
Closed -$620K – 787
2018
Q4 		$620K Buy
7,327
+309
+4% +$32.9K 0.01% 525
2018
Q3 		$1.2M Sell
7,018
-3,996
-36% -$602K 0.02% 474
2018
Q2 		$1.42M Buy
11,014
+370
+3% +$41.3K 0.02% 461
2018
Q1 		$1.1M Sell
10,644
-2,526
-19% -$250K 0.01% 500
2017
Q4 		$1.13M Sell
13,170
-31,339
-70% -$2.72M 0.01% 497
2017
Q3 		$3.78M Buy
44,509
+1,042
+2% +$82.5K 0.04% 362
2017
Q2 		$3.29M Hold
43,467
– – 0.04% 356
2017
Q1 		$2.87M Buy
43,467
+11,061
+34% +$728K 0.04% 376
2016
Q4 		$2.05M Buy
32,406
+9,275
+40% +$585K 0.03% 409
2016
Q3 		$1.47M Buy
23,131
+1,290
+6% +$94.7K 0.02% 451
2016
Q2 		$1.63M Sell
21,841
-2,260
-9% -$168K 0.02% 448
2016
Q1 		$1.61M Buy
24,101
+3,102
+15% +$189K 0.02% 426
2015
Q4 		$1.42M Buy
20,999
+8,175
+64% +$505K 0.02% 476
2015
Q3 		$685K Hold
12,824
– – 0.01% 629
2015
Q2 		$807K Sell
12,824
-19,236
-60% -$1.05M 0.01% 612
2015
Q1 		$1.54M Buy
32,060
+8,015
+33% +$307K 0.02% 515
2014
Q4 		$798K Buy
24,045
+8,015
+50% +$261K 0.01% 620
2014
Q3 		$470K Hold
16,030
– – 0.01% 633
2014
Q2 		$623K Buy
16,030
+801
+5% +$32.5K 0.01% 667
2014
Q1 		$639K Sell
15,229
-801
-5% -$33.4K 0.01% 530
2013
Q4 		$526K Buy
16,030
+1,603
+11% +$52.2K 0.01% 570
2013
Q3 		$390K Sell
14,427
-9,618
-40% -$271K ﹤0.01% 704
2013
Q2 		$561K Buy
+24,045
New +$432K 0.01% 610

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Tocqueville Asset Management's LGND Position: Q1 2019 in Review

Tocqueville Asset Management sold out of Ligand Pharmaceuticals (LGND) in Q1 2019, closing a stake of 7,327 shares — an estimated $620K sold.

Tocqueville Asset Management first reported a position in LGND in Q2 2013 and held it in 23 quarters. The position peaked at $3.78M in Q3 2017. 330 funds tracked by Wall St. Rank hold LGND as of Q1 2019.

  • Tocqueville Asset Management reported no remaining Ligand Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Tocqueville Asset Management sold 7,327 Ligand Pharmaceuticals shares in Q1 2019, an estimated $620K.
  • Tocqueville Asset Management first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 23 quarters.
  • Tocqueville Asset Management's Ligand Pharmaceuticals position peaked at $3.78M in Q3 2017.
  • 330 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2019.

Based on Tocqueville Asset Management's 13F filing for Q1 2019, filed 30 Apr 2019.